Needle Free Injections Market

Needle-Free Injections Market By Product Type (Fillable And Prefilled), By Technology (Jet-Based, Spring-Based, And Others), By Usability (Reusable And Disposable), By Application (Vaccine, Insulin, Dermatology, And Others), By End User (Hosptials, Clinics, Homecare Settings, And Others), by geography is expected to grow at a steady CAGR forecast till 2027 owing to the increased risk of communicable infections as a result of needle injuries and needle phobia among the population.

 

The Global Needle-Free Injection Systems Market was valued at USD 12.49 billion in 2021, growing at a CAGR of 14.16% during the forecast period from 2022 to 2027 to reach USD 27.65 billion by 2027. The demand for needle-free injection systems is witnessing a growth due to the rising prevalence of chronic diseases, expanding number of needle-stick injuries, increasing requirement of self-injection devices, growing number of vaccination programs, and technological innovation in product development, among other factors.

 

Needle Free Injections Market

 

Needle-Free Injections Market Dynamics:

Needle-free injection technology encompasses a wide spectrum of technology that includes a wide variety of drug delivery systems which help in the administration of drugs through the skin using pressure combining different modes, pushing the drug through the skin, thereby eliminating the need for a hypodermic needle.

 

One of the major factors influencing the growth of the needle-free injections market is the rising number of needle stick injuries among patients and caregivers. As per the data provided by the World Health Organization (2019), globally more than two million occupational exposures to sharp injuries occur among 35 million healthcare workers annually.

 

According to the Centers for Disease Control and Prevention (CDC) and European Agency for Safety and Health at Work (EU-Occupation Safety and Health Administration) reports published in 2019, there are more than 385,000 and 1,000,000 needle stick injury cases annually among hospital healthcare workers in the United States and Europe, respectively.

 

Needle-stick injuries increase the risk of more than 20 types of blood-borne infectious diseases which include HIV, hepatitis C, and hepatitis B. In addition to becoming infected with a blood-borne pathogens, needle stick injuries may result in chronic diseases and also cause psychological effects. Furthermore, the management of needle stick and sharp injuries can be cost intensive. Therefore, owing to the abovementioned factors, there is a growing need for needle-free injection systems in the market which allow for the safe administration drugs and therapeutics as well improve the safety prospects of the healthcare providers, caregivers, and patients. 

 

Moreover, the rising prevalence of chronic diseases, such as the diabetes is also one of the major factors aiding in the needle-free injections market growth.

 

According to the data provided by the International Diabetes Federation (IDF) Diabetes Atlas Ninth Edition 2019, there were approximately 463 million adults (20-79 years) suffering from diabetes across the globe. The figures are expected to reach to 700 million by 2045. It further stated that over 20 million live births (1 in 6 live births) are affected by diabetes during pregnancy. Moreover, 374 million people are at increased risk of developing type 2 diabetes. In addition to abovementioned facts, as per IDF, an estimated number of 223 million women (20-79 years) living with diabetes. This number is projected to increase to 343 million by 2045.

 

People suffering from diabetes require regular administration of insulin as one of their key treatment regimens. Many diabetes patients require multiple daily doses of insulin, and often experience anxiety and pain associated with injections. Needle-free injections offer a virtually painless method for the administration of insulin by themselves in a precise manner and thereby improving in the adherence of treatment and compliance by patients.

 

Moreover, the increased focused on providing COVID-19 vaccines to majority of the population has also resulted in the increased demand for needle free injection devices as many pharmaceutical companies are entering into partnerships with needle-free injections manufacturers for expanding their customer reach.

 

Therefore, the rising prevalence of chronic diseases, increasing number of needle stick injuries, coupled with the growing demand for safer self-injection devices are projected to drive the needle-free injections market growth.

 

However, higher requirement for training and device maintenance, limitations in the route of administration, and limitations in the variation in the design size may prove to be certain restraints to the needle-free injections market growth.

Needle-Free Injections Market Segment Analysis:

Needle-Free Injections market by Product Type (Fillable and Prefilled), by Technology (Jet-Based, Spring-Based, and Others), by Usability (Reusable and Disposable), by Application (Vaccine, Insulin, Dermatology, And Others), by End User (Hospitals, Clinics, Homecare Settings, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

 

In the application segment of the needle-free injections market, the insulin delivery needle-free injections are expected to account for the significant share in the market during the forecast period. This can be attributed to the rising prevalence of diabetic population across the globe. Moreover, diabetics require multiple doses of insulin in a day, which can be a daunting process for patients in case of using conventional syringes and needles for insulin administration. These devices aid in the easy administration of insulin through the nozzle orifice, which results in the generation of a fine stream of insulin. This stream then easily penetrates the skin. Needle-free insulin injection systems offer the least resistant path for insulin administration, thereby facilitating in the even spreading of the insulin in the subcutaneous layer.

 

Therefore, Needle-free injection devices for insulin administration are gaining popularity and are more extensively used than for other applications owing to the above stated reason.

North America is expected to dominate the Overall Needle-Free Injections Market:

Among all the regions, North America is expected to account for the largest share in the needle-free injections market. The growing number of chronic diseases, more focus on the vaccination programs, and access to better healthcare infrastructure along with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the needle free injections systems market over the forecast period.

 

As per the data provided by the Centers for Disease Control and Prevention, Flu activity was unusually low throughout the 2020-2021 flu season both in the United States and globally, despite high levels of testing. During September 28, 2020–May 22, 2021 in the United States, 1,675 (0.2%) of 818,939 respiratory specimens tested by U.S. clinical laboratories were positive for an influenza virus. Even though the number of cases of influenza were low in the country in the said period, the CDC works each year to increase the number of people who receive a flu vaccine and eliminate barriers to vaccination.

 

Needle-free injection systems are also being popularly used in the administration of different vaccines including influenza vaccines. As flu vaccines are also commonly administered in pediatric patients as well, these systems help in the easy administration of vaccines in people suffering from needle phobia, and other apprehensions. One example of this is the PharmaJet Stratis Needle-Free Injector which is the first needleless intramuscular Jet Injector approved by the US Food and Drug Administration for the  delivery of an influenza vaccine. 

 

Moreover, the well-established healthcare infrastructure in the country which can be supported by the high per capita healthcare expenditure in the country as well as the presence of highly aware patient population further encourages people to opt for such devices.

 

In August 2021, Scancell Holdings plc, a developer of novel immunotherapies announced a partnership with PharmaJEet for the utilization of PharmaJet’s needle-free injection systems for the administration of its two SARS-CoV-2 vaccine candidates, SCOV1 and SCOV2, in its COVIDITY phase 1 clinical trial (COVIDITY-001). SCOV1 and SCOV2.

 

Moreover, the increasing collaborations between the needle free injection devices manufacturers and pharmaceutical companies in the region are further to drive the market needle free injections market in the United States, and therefore in North America.

Needle-Free Injections Market Key Players:

Some of the key market players operating in the needle-free injection systems market includes IntegriMedical LLC, INJEX Pharma GmbH, PharmaJet Corporation, CrossJect, European Pharma Group BV, National Medical Products Inc, Akra DermaJet, Meika Medical Co, Basco India., Mystic Pharmaceuticals Inc, Technologies Médicales Internationales (MIT Canada) Inc., INOVIO Pharmaceuticals, MADA MEDICAL PRODUCTS INC., Portal Instruments, D'Antonio Consultants International, Inc and others.

Recent Developmental Activities in Needle-Free Injections Market:

  • In August 2021, PharmaJet and their partner Zydus Cadila announced the emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world’s first Plasmid DNA Vaccine for COVID-19. The vaccine- ZyCoV-D is exclusively administered by the deployment of the PharmaJet Tropis® Needle-free Injection System.
  • In October 2020, PharmaJet’s Needleless vaccine injector was chosen for the delivery of one of the COVID-19 vaccines- the University of Cambridge’s phase 1 trial of DIOSynVax’s candidate. The trial will test delivery of the vaccine through the skin without the use of needles.

Report Metrics

Details

Study Period

2019 to 2027

Base Year

2021

Forecast Period

2022 to 2027

CAGR

14.16%

Market Size

USD 27.65 billion by 2027

Key Companies

IntegriMedical LLC, INJEX Pharma GmbH, PharmaJet Corporation, CrossJect, European Pharma Group BV, National Medical Products Inc, Akra DermaJet, Meika Medical Co, Basco India., Mystic Pharmaceuticals Inc, Technologies Médicales Internationales (MIT Canada) Inc., INOVIO Pharmaceuticals, MADA MEDICAL PRODUCTS INC.,  Portal Instruments, D'Antonio Consultants International, Inc and others.

Key Takeaways from the Needle-Free Injections Market Report Study

  • Market size analysis for current  needle-free injections market size (2021), and market forecast for 5 years (2022-2027)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the needle-free injections market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global needle-free injections market
  • Various opportunities available for the other competitor in the needle-free injections market space.
  • What are the top performing segments in 2021? How these segments will perform in 2027?
  • Which is the top-performing regions and countries in the current needle-free injections market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for needle-free injections market growth in the coming future?

Target Audience who can be benefited from this Needle-Free Injections Market Report Study

  • Needle free injection systems products providers
  • Research organizations and consulting companies
  • Needle free injection systems -related organization, association, forum, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in needle-free injections market
  • Various End-users who want to know more about the needle-free injections market and latest technological developments in the needle-free injections market

Frequently Asked Questions for Needle-Free Injections Market:

1. What is a Needle Free Injection System?

Needle-free injection technology encompasses a wide spectrum of technology that includes a wide variety of drug delivery systems which help in the administration of drugs through the skin using pressure combining different modes, pushing the drug through the skin, thereby eliminating the need for a hypodermic needle.

 

2. What is the market for Global Needle-Free Injections?

Global Needle-Free Injection Systems Market was valued at USD 12.49 billion in 2021, growing at a CAGR of 14.16% during the forecast period from 2022 to 2027 to reach USD 27.65 billion by 2027.

 

3. What are the drivers for Global Needle-Free Injections Market?

The major drivers of the global needle-free injections market growth are rising prevalence of chronic diseases, increasing number of needle stack and sharp injuries, , rising number of trauma cases, among other factors.

 

4. What are the key players operating in Global Needle-Free Injections Market?

Some of the key market players operating in the needle-free injection systems market includes IntegriMedical LLC, INJEX Pharma GmbH, PharmaJet Corporation, CrossJect, European Pharma Group BV, National Medical Products Inc, Akra DermaJet, Meika Medical Co, Basco India., Mystic Pharmaceuticals Inc, Technologies Médicales Internationales (MIT Canada) Inc., INOVIO Pharmaceuticals, MADA MEDICAL PRODUCTS INC.,  Portal Instruments, D'Antonio Consultants International, Inc and others.

 

5. What regions has the highest share in Needle-Free Injections market?

North America is expected to dominate the overall Needle-Free Injections market during the forecast period, 2022 to 2027. The accumulation of the highest revenue in the market can be ascribed to the rising prevalence of chronic diseases, increased focus on vaccination programs, improving the safety for healthcare providers, and the increasing collaborations between key market players in the region.

1. Needle-Free Injections Market Report Introduction

2. Needle-Free Injections Market Executive Summary

2.1. Scope of the Study

2.2. Market at Glance

2.3. Competitive Assessment

2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

3.1. The United States

3.2. Europe

3.2.1. Germany

3.2.2. France

3.2.3. Italy

3.2.4. Spain

3.2.5. U.K.

3.3. Japan

4. Needle-Free Injections Market Key Factors Analysis

4.1. Needle-Free Injections Market Drivers

4.1.1. Rising Prevalence of Chronic Diseases

4.1.2. Rising Number of Needle Stick Injuries

4.1.3. Growing Focus on Vaccination Programs

4.1.4. Technological Innovation in Product Development

4.2. Market Restraints and Challenges

4.2.1. High Device Maintenance and Requirement of Training

4.2.2. Limitation with Product Design

4.3. Market Opportunities

4.3.1. Enhancing Product Design

4.3.2. Targeting Emerging Markets for Product Launches

5. Needle-Free Injections Market Porter’s Five Forces Analysis

5.1. Bargaining Power of Suppliers

5.2. Bargaining Power of Consumers

5.3. Threat of New Entrants

5.4. Threat of Substitutes

5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Needle-Free Injections Market

7. Needle-Free Injections Market Layout

7.1. By Product Type

7.1.1. Fillable

7.1.2. Prefilled

7.2. By Technology

7.2.1. Jet-Based

7.2.2. Spring-Based

7.2.3. Others

7.3. By Usability

7.3.1. Reusable

7.3.2. Disposable

7.4. By Application

7.4.1. Vaccine

7.4.2. Insulin

7.4.3. Dermatology

7.4.4. Others

7.5. By End User

7.5.1. Hospitals

7.5.2. Clinics

7.5.3. Homecare Settings

7.5.4. Others

7.6. By Geography

7.6.1. North America

7.6.1.1. North America Needle-Free Injections Market, by Product Type

7.6.1.2. North America Needle-Free Injections Market, by Technology

7.6.1.3. North America Needle-Free Injections Market, by Usability

7.6.1.4. North America Needle-Free Injections Market, by Application

7.6.1.5. North America Needle-Free Injections Market, by End User

7.6.1.6. North America Needle-Free Injections Market, by Country

7.6.1.6.1. United States

7.6.1.6.2. Canada

7.6.1.6.3. Mexico

7.6.2. Europe

7.6.2.1. Europe Needle-Free Injections Market, by Product Type

7.6.2.2. Europe Needle-Free Injections Market, by Technology

7.6.2.3. Europe Needle-Free Injections Market, by Usability

7.6.2.4. Europe Needle-Free Injections Market, by Application

7.6.2.5. Europe Needle-Free Injections Market, by End User

7.6.2.6. Europe Needle-Free Injections Market, by Country

7.6.2.6.1. France

7.6.2.6.2. Germany

7.6.2.6.3. United Kingdom

7.6.2.6.4. Italy

7.6.2.6.5. Spain

7.6.2.6.6. Russia

7.6.2.6.7. Rest of Europe

7.6.3. Asia-Pacific

7.6.3.1. Asia-Pacific Needle-Free Injections Market, by Product Type

7.6.3.2. Asia-Pacific Needle-Free Injections Market, by Technology

7.6.3.3. Asia-Pacific Needle-Free Injections Market, by Usability

7.6.3.4. Asia-Pacific Needle-Free Injections Market, by Application

7.6.3.5. Asia-Pacific Needle-Free Injections Market, by End User

7.6.3.6. Asia-Pacific Needle-Free Injections Market, by Country

7.6.3.6.1. China

7.6.3.6.2. Japan

7.6.3.6.3. India

7.6.3.6.4. Australia

7.6.3.6.5. South Korea

7.6.3.6.6. Rest of Asia Pacific

7.6.4. Rest of the World (RoW)

7.6.4.1. RoW Needle-Free Injections Market, by Product Type

7.6.4.2. RoW Needle-Free Injections Market, by Technology

7.6.4.3. RoW Needle-Free Injections Market, by Usability

7.6.4.4. RoW Needle-Free Injections Market, by Application

7.6.4.5. RoW Needle-Free Injections Market, by End User

7.6.4.6. RoW Needle-Free Injections Market, by Country

7.6.4.4.1. Middle East

7.6.4.4.2. Africa

7.6.4.4.3. South America

8. Needle-Free Injections Market Global Company Share Analysis – Key 3-5 Companies

9. Needle-Free Injections Market Company and Product Profiles

9.1. IntegriMedical LLC

9.1.1. Company Overview

9.1.2. Company Snapshot

9.1.3. Financial Overview

9.1.4. Product Listing

9.1.5. Entropy

9.2. INJEX Pharma GmbH

9.2.1. Company Overview

9.2.2. Company Snapshot

9.2.3. Financial Overview

9.2.4. Product Listing

9.2.5. Entropy

9.3. PharmaJet

9.3.1. Company Overview

9.3.2. Company Snapshot

9.3.3. Financial Overview

9.3.4. Product Listing

9.3.5. Entropy

9.4. CrossJect

9.4.1. Company Overview

9.4.2. Company Snapshot

9.4.3. Financial Overview

9.4.4. Product Listing

9.4.5. Entropy

9.5. European Pharma Group BV

9.5.1. Company Overview

9.5.2. Company Snapshot

9.5.3. Financial Overview

9.5.4. Product Listing

9.5.5. Entropy

9.6. National Medical Products Inc

9.6.1. Company Overview

9.6.2. Company Snapshot

9.6.3. Financial Overview

9.6.4. Product Listing

9.6.5. Entropy

9.7. Akra DermaJet

9.7.1. Company Overview

9.7.2. Company Snapshot

9.7.3. Financial Overview

9.7.4. Product Listing

9.7.5. Entropy

9.8. Meika Medical CO.

9.8.1. Company Overview

9.8.2. Company Snapshot

9.8.3. Financial Overview

9.8.4. Product Listing

9.8.5. Entropy

9.9. Basco India

9.9.1. Company Overview

9.9.2. Company Snapshot

9.9.3. Financial Overview

9.9.4. Product Listing

9.9.5. Entropy

9.10. Mystic Pharmaceuticals Inc

9.10.1. Company Overview

9.10.2. Company Snapshot

9.10.3. Financial Overview

9.10.4. Product Listing

9.10.5. Entropy

9.11. Technologies Médicales Internationales (MIT Canada) Inc.

9.11.1. Company Overview

9.11.2. Company Snapshot

9.11.3. Financial Overview

9.11.4. Product Listing

9.11.5. Entropy

9.12. INOVIO Pharmaceuticals

9.12.1. Company Overview

9.12.2. Company Snapshot

9.12.3. Financial Overview

9.12.4. Product Listing

9.12.5. Entropy

9.13. MADA MEDICAL PRODUCTS INC

9.13.1. Company Overview

9.13.2. Company Snapshot

9.13.3. Financial Overview

9.13.4. Product Listing

9.13.5. Entropy

9.14. Portal Instruments

9.14.1. Company Overview

9.14.2. Company Snapshot

9.14.3. Financial Overview

9.14.4. Product Listing

9.14.5. Entropy

9.15. D'Antonio Consultants International, Inc

9.13.1. Company Overview

9.13.2. Company Snapshot

9.13.3. Financial Overview

9.13.4. Product Listing

9.13.5. Entropy

10. Project Approach

10.1. Secondary Sources

10.2. Primary Sources

10.3. Data Triangulation

10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: COVID-19 Impact Analysis on Needle-Free Injections Market

Table 3: Needle-Free Injections Market in Global (2019-2027)

Table 4: Needle-Free Injections Market in Global by Product Type (2019-2027)

Table 5: Needle-Free Injections Market in Global by Technology (2019-2027)

Table 6: Needle-Free Injections Market in Global by Usability (2019-2027)

Table 7: Needle-Free Injections Market in Global by Application (2019-2027)

Table 8: Needle-Free Injections Market in Global by End User (2019-2027)

Table 9: Needle-Free Injections Market in Global by Geography (2019-2027)

Table 10: Needle-Free Injections Market in North America (2019-2027)

Table 11: Needle-Free Injections Market in North America by Product Type (2019-2027)

Table 12: Needle-Free Injections Market in North America by Technology (2019-2027)

Table 13: Needle-Free Injections Market in Global by Usability (2019-2027)

Table 14: Needle-Free Injections Market in North America by Application (2019-2027)

Table 15: Needle-Free Injections Market in North America by End User (2019-2027)

Table 16: Needle-Free Injections Market in North America by Country (2019-2027)

Table 17: Needle-Free Injections Market in the US (2019-2027)

Table 18: Needle-Free Injections Market in Canada (2019-2027)

Table 19: Needle-Free Injections Market in Mexico (2019-2027)

Table 20: Needle-Free Injections Market in Europe (2019-2027)

Table 21: Needle-Free Injections Market in Europe by Product Type (2019-2027)

Table 22: Needle-Free Injections Market in Europe by Technology (2019-2027)

Table 23: Needle-Free Injections Market in Global by Usability (2019-2027)

Table 24: Needle-Free Injections Market in Europe by Application (2019-2027)

Table 25: Needle-Free Injections Market in Europe by End User (2019-2027)

Table 26: Needle-Free Injections Market in Europe by Country (2019-2027)

Table 27: Needle-Free Injections Market in France (2019-2027)

Table 28: Needle-Free Injections Market in Germany (2019-2027)

Table 29: Needle-Free Injections Market in the United Kingdom (2019-2027)

Table 30: Needle-Free Injections Market in Italy (2019-2027)

Table 31: Needle-Free Injections Market in Spain (2019-2027)

Table 32: Needle-Free Injections Market in Russia (2019-2027)

Table 33: Needle-Free Injections Market in Rest of Europe (2019-2027)

Table 34: Needle-Free Injections Market in APAC (2019-2027)

Table 35: Needle-Free Injections Market in APAC by Product Type (2019-2027)

Table 36: Needle-Free Injections Market in APAC by Technology (2019-2027)

Table 37: Needle-Free Injections Market in Global by Usability (2019-2027)

Table 38: Needle-Free Injections Market in APAC by Application (2019-2027)

Table 39: Needle-Free Injections Market in APAC by End User (2019-2027)

Table 40: Needle-Free Injections Market in APAC by Country (2019-2027)

Table 41: Needle-Free Injections Market in China (2019-2027)

Table 42: Needle-Free Injections Market in Japan (2019-2027)

Table 43: Needle-Free Injections Market in India (2019-2027)

Table 44: Needle-Free Injections Market in Australia (2019-2027)

Table 45: Needle-Free Injections Market in South Korea (2019-2027)

Table 46: Needle-Free Injections Market in Rest of APAC (2019-2027)

Table 47: Needle-Free Injections Market in Rest of World (2019-2027)

Table 48: Needle-Free Injections Market in RoW by Product Type (2019-2027)

Table 49: Needle-Free Injections Market in RoW by Technology (2019-2027)

Table 50: Needle-Free Injections Market in Global by Usability (2019-2027)

Table 51: Needle-Free Injections Market in RoW by Application (2019-2027)

Table 52: Needle-Free Injections Market in RoW by End User (2019-2027)

Table 53: Needle-Free Injections Market in RoW by Region (2019-2027)

Table 54: Needle-Free Injections Market in Middle East (2019-2027)

Table 55: Needle-Free Injections Market in Africa (2019-2027)

Table 56: Needle-Free Injections Market in South America (2019-2027)

List of Figures

Figure 1: Competitive Analysis

Figure 2: COVID-19 Impact Analysis on Needle-Free Injections Market

Figure 3: Needle-Free Injections Market in Global (2019-2027)

Figure 4: Needle-Free Injections Market in Global by Product Type (2019-2027)

Figure 5: Needle-Free Injections Market in Global by Technology (2019-2027)

Figure 6: Needle-Free Injections Market in Global by Usability (2019-2027)

Figure 7: Needle-Free Injections Market in Global by Application (2019-2027)

Figure 8: Needle-Free Injections Market in Global by End User (2019-2027)

Figure 9: Needle-Free Injections Market in Global by Geography (2019-2027)

Figure 10: Needle-Free Injections Market in North America (2019-2027)

Figure 11: Needle-Free Injections Market in North America by Product Type (2019-2027)

Figure 12: Needle-Free Injections Market in North America by Technology (2019-2027)

Figure 13: Needle-Free Injections Market in Global by Usability (2019-2027)

Figure 14: Needle-Free Injections Market in North America by Application (2019-2027)

Figure 15: Needle-Free Injections Market in North America by End User (2019-2027)

Figure 16: Needle-Free Injections Market in North America by Country (2019-2027)

Figure 17: Needle-Free Injections Market in the US (2019-2027)

Figure 18: Needle-Free Injections Market in Canada (2019-2027)

Figure 19: Needle-Free Injections Market in Mexico (2019-2027)

Figure 20: Needle-Free Injections Market in Europe (2019-2027)

Figure 21: Needle-Free Injections Market in Europe by Product Type (2019-2027)

Figure 22: Needle-Free Injections Market in Europe by Technology (2019-2027)

Figure 23: Needle-Free Injections Market in Global by Usability (2019-2027)

Figure 24: Needle-Free Injections Market in Europe by Application (2019-2027)

Figure 25: Needle-Free Injections Market in Europe by End User (2019-2027)

Figure 26: Needle-Free Injections Market in Europe by Country (2019-2027)

Figure 27: Needle-Free Injections Market in France (2019-2027)

Figure 28: Needle-Free Injections Market in Germany (2019-2027)

Figure 29: Needle-Free Injections Market in the United Kingdom (2019-2027)

Figure 30: Needle-Free Injections Market in Italy (2019-2027)

Figure 31: Needle-Free Injections Market in Spain (2019-2027)

Figure 32: Needle-Free Injections Market in Russia (2019-2027)

Figure 33: Needle-Free Injections Market in Rest of Europe (2019-2027)

Figure 34: Needle-Free Injections Market in APAC (2019-2027)

Figure 35: Needle-Free Injections Market in APAC by Product Type (2019-2027)

Figure 36: Needle-Free Injections Market in APAC by Technology (2019-2027)

Figure 37: Needle-Free Injections Market in Global by Usability (2019-2027)

Figure 38: Needle-Free Injections Market in APAC by Application (2019-2027)

Figure 39: Needle-Free Injections Market in APAC by End User (2019-2027)

Figure 40: Needle-Free Injections Market in APAC by Country (2019-2027)

Figure 41: Needle-Free Injections Market in China (2019-2027)

Figure 42: Needle-Free Injections Market in Japan (2019-2027)

Figure 43: Needle-Free Injections Market in India (2019-2027)

Figure 44: Needle-Free Injections Market in Australia (2019-2027)

Figure 45: Needle-Free Injections Market in South Korea (2019-2027)

Figure 46: Needle-Free Injections Market in Rest of APAC (2019-2027)

Figure 47: Needle-Free Injections Market in Rest of World (2019-2027)

Figure 48: Needle-Free Injections Market in RoW by Product Type (2019-2027)

Figure 49: Needle-Free Injections Market in RoW by Technology (2019-2027)

Figure 50: Needle-Free Injections Market in Global by Usability (2019-2027)

Figure 51: Needle-Free Injections Market in RoW by Application (2019-2027)

Figure 52: Needle-Free Injections Market in RoW by End User (2019-2027)

Figure 53: Needle-Free Injections Market in RoW by Region (2019-2027)

Figure 54: Needle-Free Injections Market in Middle East (2019-2027)

Figure 55: Needle-Free Injections Market in Africa (2019-2027)

Figure 56: Needle-Free Injections Market in South America (2019-2027)

Figure 57: Market Drivers

Figure 58: Market Barriers

Figure 59: Marker Opportunities

Figure 60: PORTER'S Five Force Analysis

IntegriMedical LLC

INJEX Pharma GmbH

PharmaJet Corporation

CrossJect

European Pharma Group BV

National Medical Products Inc

Akra DermaJet

Meika Medical Co

Basco India.

Mystic Pharmaceuticals Inc

Technologies Médicales Internationales (MIT Canada) Inc.

INOVIO Pharmaceuticals

MADA MEDICAL PRODUCTS INC.

Portal Instruments

D'Antonio Consultants International, Inc

Forward to Friend

Need A Quote